Novartis - Quarterly Results
8th Aug 2019

Net sales declined -20.85%  to  Rs. 1093.10 million from Rs. 1381.00 millions.The company reported a drastic decline of -92.10% in the quarter ended June 2019 to Rs. 7.90  millions from Rs. 100.00 millions  .A decline of 56.90 millions was observed in the OP in the quarter ended June 2019 from 187.80 millions on QoQ basis.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201906 201806 % Var 201906 201806 % Var 201903 201803 % Var
Sales 1093.10 1381.00 -20.85 1093.10 1381.00 -20.85 4906.80 5638.90 -12.98
Other Income 108.90 222.80 -51.12 108.90 222.80 -51.12 782.60 1718.30 -54.45
PBIDT 56.90 187.80 -69.70 56.90 187.80 -69.70 905.40 1655.80 -45.32
Interest 11.60 15.30 -24.18 11.60 15.30 -24.18 15.90 55.30 -71.25
PBDT 45.30 172.50 -73.74 45.30 172.50 -73.74 889.50 1600.50 -44.42
Depreciation 32.20 6.60 387.88 32.20 6.60 387.88 31.80 25.30 25.69
PBT 13.10 165.90 -92.10 13.10 165.90 -92.10 857.70 1575.20 -45.55
TAX 5.20 65.90 -92.11 5.20 65.90 -92.11 340.00 791.60 -57.05
Deferred Tax -0.50 0.60 -183.33 -0.50 0.60 -183.33 7.30 -4.70 -255.32
PAT 7.90 100.00 -92.10 7.90 100.00 -92.10 517.70 783.60 -33.93
Equity 123.40 123.40 0.00 123.40 123.40 0.00 123.40 123.40 0.00
PBIDTM(%) 5.21 13.60 -61.72 5.21 13.60 -61.72 18.45 29.36 -37.16